메뉴 건너뛰기




Volumn 22, Issue 7, 2015, Pages 1048-1055

Association of improved outcome in acute ischaemic stroke patients with atrial fibrillation who receive early antithrombotic therapy: Analysis from VISTA

Author keywords

Antithrombotics; Atrial fibrillation; Intracerebral haemorrhage; Stroke

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; FIBRINOLYTIC AGENT;

EID: 84930748131     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/ene.12577     Document Type: Article
Times cited : (68)

References (29)
  • 1
    • 0025779484 scopus 로고
    • Atrial fibrillation as an independent risk factor for stroke: the Framingham Study
    • Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991; 22: 983-988.
    • (1991) Stroke , vol.22 , pp. 983-988
    • Wolf, P.A.1    Abbott, R.D.2    Kannel, W.B.3
  • 2
    • 77956403095 scopus 로고    scopus 로고
    • Early recurrent ischemic stroke complicating intravenous thrombolysis for stroke
    • Awadh M, MacDougall N, Santosh C, Teasdale E, Baird T, Muir KW. Early recurrent ischemic stroke complicating intravenous thrombolysis for stroke. Stroke 2010; 41: 1990-1995.
    • (2010) Stroke , vol.41 , pp. 1990-1995
    • Awadh, M.1    MacDougall, N.2    Santosh, C.3    Teasdale, E.4    Baird, T.5    Muir, K.W.6
  • 3
    • 33646782452 scopus 로고    scopus 로고
    • Stroke prevention with aspirin, warfarin and ximelagatran in patients with non-valvular atrial fibrillation: a systematic review and meta-analysis
    • Lip GY, Edwards SJ. Stroke prevention with aspirin, warfarin and ximelagatran in patients with non-valvular atrial fibrillation: a systematic review and meta-analysis. Thromb Res 2006; 118: 321-333.
    • (2006) Thromb Res , vol.118 , pp. 321-333
    • Lip, G.Y.1    Edwards, S.J.2
  • 4
    • 84855890591 scopus 로고    scopus 로고
    • New frontiers for stroke prevention in atrial fibrillation
    • Prasad V, Kaplan RM, Passman RS. New frontiers for stroke prevention in atrial fibrillation. Cerebrovasc Dis 2012; 33: 199-208.
    • (2012) Cerebrovasc Dis , vol.33 , pp. 199-208
    • Prasad, V.1    Kaplan, R.M.2    Passman, R.S.3
  • 5
    • 44449094159 scopus 로고    scopus 로고
    • Guidelines for management of ischaemic stroke and transient ischaemic attack 2008
    • European Stroke Organisation (ESO) Executive Committee, and the ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 2008; 25: 457-507.
    • (2008) Cerebrovasc Dis , vol.25 , pp. 457-507
  • 6
    • 84876231902 scopus 로고    scopus 로고
    • Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association
    • Jauch EC, Saver JL, Adams HP Jr, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2013; 44: 870-947.
    • (2013) Stroke , vol.44 , pp. 870-947
    • Jauch, E.C.1    Saver, J.L.2    Adams, H.P.3
  • 7
    • 49849087132 scopus 로고    scopus 로고
    • Early hemorrhagic transformation of brain infarction: rate, predictive factors, and influence on clinical outcome: results of a prospective multicenter study
    • Paciaroni M, Agnelli G, Corea F, et al. Early hemorrhagic transformation of brain infarction: rate, predictive factors, and influence on clinical outcome: results of a prospective multicenter study. Stroke 2008; 39: 2249-2256.
    • (2008) Stroke , vol.39 , pp. 2249-2256
    • Paciaroni, M.1    Agnelli, G.2    Corea, F.3
  • 8
    • 78650418065 scopus 로고    scopus 로고
    • Asymptomatic hemorrhagic transformation of infarction and its relationship with functional outcome and stroke subtype: assessment from the Tinzaparin in Acute Ischaemic Stroke Trial
    • England TJ, Bath PM, Sare GM, et al. Asymptomatic hemorrhagic transformation of infarction and its relationship with functional outcome and stroke subtype: assessment from the Tinzaparin in Acute Ischaemic Stroke Trial. Stroke 2010; 41: 2834-2839.
    • (2010) Stroke , vol.41 , pp. 2834-2839
    • England, T.J.1    Bath, P.M.2    Sare, G.M.3
  • 9
    • 84877921154 scopus 로고    scopus 로고
    • Targeted use of heparin, heparinoids, or low-molecular-weight heparin to improve outcome after acute ischaemic stroke: an individual patient data meta-analysis of randomised controlled trials
    • Whiteley WN, Adams HP Jr, Bath PM, et al. Targeted use of heparin, heparinoids, or low-molecular-weight heparin to improve outcome after acute ischaemic stroke: an individual patient data meta-analysis of randomised controlled trials. Lancet Neurol 2013; 12: 539-545.
    • (2013) Lancet Neurol , vol.12 , pp. 539-545
    • Whiteley, W.N.1    Adams, H.P.2    Bath, P.M.3
  • 10
    • 33846649116 scopus 로고    scopus 로고
    • Efficacy and safety of anticoagulant treatment in acute cardioembolic stroke: a meta-analysis of randomized controlled trials
    • Paciaroni M, Agnelli G, Micheli S, Caso V. Efficacy and safety of anticoagulant treatment in acute cardioembolic stroke: a meta-analysis of randomized controlled trials. Stroke 2007; 38: 423-430.
    • (2007) Stroke , vol.38 , pp. 423-430
    • Paciaroni, M.1    Agnelli, G.2    Micheli, S.3    Caso, V.4
  • 11
    • 84856145783 scopus 로고    scopus 로고
    • Development, expansion, and use of a stroke clinical trials resource for novel exploratory analyses
    • Ali M, Bath P, Brady M, et al. Development, expansion, and use of a stroke clinical trials resource for novel exploratory analyses. Int J Stroke 2012; 7: 133-138.
    • (2012) Int J Stroke , vol.7 , pp. 133-138
    • Ali, M.1    Bath, P.2    Brady, M.3
  • 12
    • 39649090053 scopus 로고    scopus 로고
    • The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
    • von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 2008; 61: 344-349.
    • (2008) J Clin Epidemiol , vol.61 , pp. 344-349
    • von Elm, E.1    Altman, D.G.2    Egger, M.3
  • 14
    • 0020574025 scopus 로고
    • Early recurrent embolism associated with nonvalvular atrial fibrillation: a retrospective study
    • Hart RG, Coull BM, Hart D. Early recurrent embolism associated with nonvalvular atrial fibrillation: a retrospective study. Stroke 1983; 14: 688-693.
    • (1983) Stroke , vol.14 , pp. 688-693
    • Hart, R.G.1    Coull, B.M.2    Hart, D.3
  • 15
    • 0021191497 scopus 로고
    • Cerebral ischemia and atrial fibrillation: prospective study
    • Kelley RE, Berger JR, Alter M, Kovacs AG. Cerebral ischemia and atrial fibrillation: prospective study. Neurology 1984; 34: 1285-1291.
    • (1984) Neurology , vol.34 , pp. 1285-1291
    • Kelley, R.E.1    Berger, J.R.2    Alter, M.3    Kovacs, A.G.4
  • 16
    • 84865189210 scopus 로고    scopus 로고
    • New anticoagulant treatments to protect against stroke in atrial fibrillation
    • Potpara TS, Lip GY, Apostolakis S. New anticoagulant treatments to protect against stroke in atrial fibrillation. Heart 2012; 98: 1341-1347.
    • (2012) Heart , vol.98 , pp. 1341-1347
    • Potpara, T.S.1    Lip, G.Y.2    Apostolakis, S.3
  • 17
    • 84865138532 scopus 로고    scopus 로고
    • Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation
    • Lip GY, Larsen TB, Skjoth F, Rasmussen LH. Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation. J Am Coll Cardiol 2012; 60: 738-746.
    • (2012) J Am Coll Cardiol , vol.60 , pp. 738-746
    • Lip, G.Y.1    Larsen, T.B.2    Skjoth, F.3    Rasmussen, L.H.4
  • 18
    • 84869202253 scopus 로고    scopus 로고
    • Primary and secondary prevention with new oral anticoagulant drugs for stroke prevention in atrial fibrillation: indirect comparison analysis
    • Rasmussen LH, Larsen TB, Graungaard T, Skjoth F, Lip GY. Primary and secondary prevention with new oral anticoagulant drugs for stroke prevention in atrial fibrillation: indirect comparison analysis. BMJ 2012; 345: e7097.
    • (2012) BMJ , vol.345 , pp. e7097
    • Rasmussen, L.H.1    Larsen, T.B.2    Graungaard, T.3    Skjoth, F.4    Lip, G.Y.5
  • 19
    • 70349306707 scopus 로고    scopus 로고
    • Dabigatran versus warfarin in patients with atrial fibrillation
    • Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009; 361: 1139-1151.
    • (2009) N Engl J Med , vol.361 , pp. 1139-1151
    • Connolly, S.J.1    Ezekowitz, M.D.2    Yusuf, S.3
  • 20
    • 80052592404 scopus 로고    scopus 로고
    • Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
    • Patel MR, Mahaffey KW, Garg J, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011; 365: 883-891.
    • (2011) N Engl J Med , vol.365 , pp. 883-891
    • Patel, M.R.1    Mahaffey, K.W.2    Garg, J.3
  • 21
    • 80052825103 scopus 로고    scopus 로고
    • Apixaban versus warfarin in patients with atrial fibrillation
    • Granger CB, Alexander JH, McMurray JJ, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2011; 365: 981-992.
    • (2011) N Engl J Med , vol.365 , pp. 981-992
    • Granger, C.B.1    Alexander, J.H.2    McMurray, J.J.3
  • 22
    • 77957699729 scopus 로고    scopus 로고
    • Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)
    • European Heart Rhythm Association, European Association for Cardio-Thoracic Surgeons, Camm AJ, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010; 31: 2369-2429.
    • (2010) Eur Heart J , vol.31 , pp. 2369-2429
    • Camm, A.J.1
  • 25
    • 76749163232 scopus 로고    scopus 로고
    • Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on Atrial Fibrillation
    • Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on Atrial Fibrillation. Chest 2010; 137: 263-272.
    • (2010) Chest , vol.137 , pp. 263-272
    • Lip, G.Y.1    Nieuwlaat, R.2    Pisters, R.3    Lane, D.A.4    Crijns, H.J.5
  • 26
    • 77956899158 scopus 로고    scopus 로고
    • Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation
    • Hansen ML, Sorensen R, Clausen MT, et al. Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation. Arch Intern Med 2010; 170: 1433-1441.
    • (2010) Arch Intern Med , vol.170 , pp. 1433-1441
    • Hansen, M.L.1    Sorensen, R.2    Clausen, M.T.3
  • 27
    • 84873569160 scopus 로고    scopus 로고
    • Concomitant use of antiplatelet therapy with dabigatran or warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial
    • Dans AL, Connolly SJ, Wallentin L, et al. Concomitant use of antiplatelet therapy with dabigatran or warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial. Circulation 2013; 127: 634-640.
    • (2013) Circulation , vol.127 , pp. 634-640
    • Dans, A.L.1    Connolly, S.J.2    Wallentin, L.3
  • 28
    • 0030911057 scopus 로고    scopus 로고
    • The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke
    • International Stroke Trial Collaborative Group. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. Lancet 1997; 349: 1569-1581.
    • (1997) Lancet , vol.349 , pp. 1569-1581
  • 29
    • 0030985284 scopus 로고    scopus 로고
    • CAST: randomised placebo-controlled trial of early aspirin use in 20 000 patients with acute ischaemic stroke
    • Chen Z-M. CAST: randomised placebo-controlled trial of early aspirin use in 20 000 patients with acute ischaemic stroke. Lancet 1997; 349: 1641-1649.
    • (1997) Lancet , vol.349 , pp. 1641-1649
    • Chen, Z.-M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.